PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
77011934 |
LAW OFFICE ASSIGNED |
LAW OFFICE 105 |
MARK SECTION |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
FABOOST |
OWNER SECTION (current) |
NAME |
Bayer Schering Pharma Aktiengesellschaft |
STREET |
Muellerstrasse 178 |
CITY |
Berlin |
ZIP/POSTAL CODE |
13353 |
COUNTRY |
Germany |
OWNER SECTION (proposed) |
NAME |
Bayer Schering Pharma Aktiengesellschaft |
STREET |
Muellerstrasse 178 |
CITY |
Berlin |
ZIP/POSTAL CODE |
13353 |
COUNTRY |
Germany |
EMAIL |
docket@flhlaw.com |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations, namely, hormonal contraceptives |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
3 |
ONGOING EFFORT |
product or service research development |
ALLOWANCE MAIL DATE |
10/23/2007 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/marilyn matthes brogan/ |
SIGNATORY'S NAME |
Marilyn Matthes Brogan |
SIGNATORY'S POSITION |
attorney |
DATE SIGNED |
02/23/2009 |
FILING INFORMATION |
SUBMIT DATE |
Mon Feb 23 11:24:18 EST 2009 |
TEAS STAMP |
USPTO/ESU-XXX.X.XXX.XXX-2
0090223112418018365-77011
934-440617f8f462a8b919398
ae3ba0e4d025-DA-6679-2009
0223110719253928 |
PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: FABOOST
SERIAL NUMBER: 77011934
The applicant, Bayer Schering Pharma Aktiengesellschaft, having an address of
Muellerstrasse 178
Berlin, 13353
Germany
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 10/23/2007.
For International Class 005:
Current identification: Pharmaceutical preparations, namely, hormonal contraceptives
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: product or service research development
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /marilyn matthes brogan/ Date Signed: 02/23/2009
Signatory's Name: Marilyn Matthes Brogan
Signatory's Position: attorney
RAM Sale Number: 6679
RAM Accounting Date: 02/23/2009
Serial Number: 77011934
Internet Transmission Date: Mon Feb 23 11:24:18 EST 2009
TEAS Stamp: USPTO/ESU-XXX.X.XXX.XXX-2009022311241801
8365-77011934-440617f8f462a8b919398ae3ba
0e4d025-DA-6679-20090223110719253928